Cumulative incidence of proven or probable IFI while on-treatment. Probability of infections that occurred in patients while receiving or within 2 weeks of discontinuation of study drugs (SD) is shown. The number of patients at risk (alive and on SD) at each interval is indicated. The P value shown was calculated from tests comparing the incidences at 6 months.